Skip to main content
Erschienen in: International Urology and Nephrology 4/2019

05.12.2018 | Urology - Original paper

Urine proteomic profiling in patients with nephrolithiasis and cystinuria

verfasst von: Larisa Kovacevic, Joseph A. Caruso, Hong Lu, Natalija Kovacevic, Yegappan Lakshmanan, Nicholas J. Carruthers, David S. Goldfarb

Erschienen in: International Urology and Nephrology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study was to assess the differences in the concentration and function of urinary proteins between patients with cystine stones (CYS) and healthy controls (HC). We postulated that CYS and HC groups would demonstrate different proteomic profiles.

Methods

A pilot study was performed comparing urinary proteomes of 10 patients with CYS and 10 age- and gender-matched HC, using liquid chromatography-mass spectrometry. Proteins which met the selection criteria (i) ≥ 2 unique peptide identifications; (ii) ≥ twofold difference in protein abundance; and (iii) ≤ 0.05 p value for the Fisher’s Exact Test were analyzed using Gene Ontology classifications.

Results

Of the 2097 proteins identified by proteomic analysis, 398 proteins were significantly different between CYS and HC. Of those, 191 were involved in transport processes and 61 in inflammatory responses. The majority were vesicle-mediated transport proteins (78.5%), and 1/3 of them were down-regulated; of those, 12 proteins were involved in endosomal transport (including 6 charged multivesicular body proteins (CHMP) and 3 vacuolar sorting-associated proteins) and 9 in transmembrane transport. Myosin-2 and two actin-related proteins were significantly up-regulated in the vesicle-mediated transport group.

Conclusion

We provide proteomic evidence of impaired endocytosis, dysregulation of actin and myosin cytoskeleton, and inflammation in CYS. Endosomal transport proteins were down-regulated mainly through defective CHMP. These findings may contribute to further understanding of the pathogenesis of CYS, potentially affecting its management.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chillarón J, Font-Llitjós M, Fort J, Zorzano A, Goldfarb DS, Nunes V, Palacín M (2010) Pathophysiology and treatment of cystinuria. Nat Rev Nephrol 6(7):424–424CrossRefPubMed Chillarón J, Font-Llitjós M, Fort J, Zorzano A, Goldfarb DS, Nunes V, Palacín M (2010) Pathophysiology and treatment of cystinuria. Nat Rev Nephrol 6(7):424–424CrossRefPubMed
2.
Zurück zum Zitat Pras E, Arber N, Aksentijevich I, Katz G, Schapiro JM, Prosen L, Gruberg L, Harel D, Liberman U, Weissenbach J (1994) Localization of a gene causing cystinuria to chromosome 2p. Nat Genet 6(4):415–419CrossRefPubMed Pras E, Arber N, Aksentijevich I, Katz G, Schapiro JM, Prosen L, Gruberg L, Harel D, Liberman U, Weissenbach J (1994) Localization of a gene causing cystinuria to chromosome 2p. Nat Genet 6(4):415–419CrossRefPubMed
3.
Zurück zum Zitat Knoll T, Zollner A, Wendt-Nordahl G, Michel MS, Alken P (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20:19–24CrossRefPubMed Knoll T, Zollner A, Wendt-Nordahl G, Michel MS, Alken P (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20:19–24CrossRefPubMed
4.
Zurück zum Zitat Dahlberg PJ, Van den Berg CJ, Kurtz SB, Wilson DM, Smith LH (1977) Clinical features and management of cystinuria. Mayo Clin Proc 52:533–542PubMed Dahlberg PJ, Van den Berg CJ, Kurtz SB, Wilson DM, Smith LH (1977) Clinical features and management of cystinuria. Mayo Clin Proc 52:533–542PubMed
5.
Zurück zum Zitat Assimos DG, Leslie SW, Ng C, Streem SB, Hart LJ (2002) The impact of cystinuria on renal function. J Urol 168:27–20CrossRefPubMed Assimos DG, Leslie SW, Ng C, Streem SB, Hart LJ (2002) The impact of cystinuria on renal function. J Urol 168:27–20CrossRefPubMed
6.
7.
Zurück zum Zitat Cadieux PA, Beiko DT, Watterson JD, Burton JP, Howard JC, Knudsen BE, Gan BS, McCormick JK, Chambers AF, Denstedt JD, Reid G (2004) Surface- enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis. J Clin Lab Anal 18(3):170–175CrossRefPubMed Cadieux PA, Beiko DT, Watterson JD, Burton JP, Howard JC, Knudsen BE, Gan BS, McCormick JK, Chambers AF, Denstedt JD, Reid G (2004) Surface- enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis. J Clin Lab Anal 18(3):170–175CrossRefPubMed
8.
Zurück zum Zitat Thongboonkerd V (2007) Practical points in urinary proteomics. J Proteome Res 6(10):3881–3880CrossRefPubMed Thongboonkerd V (2007) Practical points in urinary proteomics. J Proteome Res 6(10):3881–3880CrossRefPubMed
10.
Zurück zum Zitat Eshbach ML, Weisz OA (2017) Receptor-mediated endocytosis in the proximal tubule. Annu Rev Physiol 79:425–448CrossRefPubMed Eshbach ML, Weisz OA (2017) Receptor-mediated endocytosis in the proximal tubule. Annu Rev Physiol 79:425–448CrossRefPubMed
11.
Zurück zum Zitat Bagga HS, Chi T, Miller J, Stoller ML (2013) New insights into the pathogenesis of renal calculi. Urol Clin N Am 40(1):1–12CrossRef Bagga HS, Chi T, Miller J, Stoller ML (2013) New insights into the pathogenesis of renal calculi. Urol Clin N Am 40(1):1–12CrossRef
12.
Zurück zum Zitat Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Phillips CL, Worcester EM (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69(12):2227–2235CrossRefPubMed Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Phillips CL, Worcester EM (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69(12):2227–2235CrossRefPubMed
13.
Zurück zum Zitat Sabharanjak S, Sharma P, Parton RG (2002) GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independeent pinocytic pathway. Dev Cell 2:411–423CrossRefPubMed Sabharanjak S, Sharma P, Parton RG (2002) GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independeent pinocytic pathway. Dev Cell 2:411–423CrossRefPubMed
14.
15.
Zurück zum Zitat Brooks ER, Hoppe B, Milliner DS, Salido E, Rim J, Krevitt LM, Olson JB, Price HE, Vural G, Langman CB (2016) Assessment of urine proteomics in type 1 primary hyperoxaluria. Am J Nephrol 43(4):293–303CrossRefPubMedPubMedCentral Brooks ER, Hoppe B, Milliner DS, Salido E, Rim J, Krevitt LM, Olson JB, Price HE, Vural G, Langman CB (2016) Assessment of urine proteomics in type 1 primary hyperoxaluria. Am J Nephrol 43(4):293–303CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Nagamori S, Wiriyasermkul P, Guarch ME, Okuyama H, Nakagomi S, Tadagaki K, Nishinaka Y, Bodoy S, Takafuji K, Okuda S, Kurokawa J, Ohgaki R, Nunes V, Palacín M, Kanai Y (2016) Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1. Proc Natl Acad Sci USA 113(3):775–780CrossRefPubMed Nagamori S, Wiriyasermkul P, Guarch ME, Okuyama H, Nakagomi S, Tadagaki K, Nishinaka Y, Bodoy S, Takafuji K, Okuda S, Kurokawa J, Ohgaki R, Nunes V, Palacín M, Kanai Y (2016) Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1. Proc Natl Acad Sci USA 113(3):775–780CrossRefPubMed
17.
Zurück zum Zitat Bourderioux M, Nguyen-Khoa T, Chhuon C, Jeanson L, Tondelier D, Walczak M, Ollero M, Bekri S, Knebelmann B, Escudier E, Escudier B, Edelman A, Guerrera IC (2014) A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients. J Proteome Res 14(1):567–777CrossRefPubMed Bourderioux M, Nguyen-Khoa T, Chhuon C, Jeanson L, Tondelier D, Walczak M, Ollero M, Bekri S, Knebelmann B, Escudier E, Escudier B, Edelman A, Guerrera IC (2014) A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients. J Proteome Res 14(1):567–777CrossRefPubMed
Metadaten
Titel
Urine proteomic profiling in patients with nephrolithiasis and cystinuria
verfasst von
Larisa Kovacevic
Joseph A. Caruso
Hong Lu
Natalija Kovacevic
Yegappan Lakshmanan
Nicholas J. Carruthers
David S. Goldfarb
Publikationsdatum
05.12.2018
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 4/2019
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-018-2044-1

Weitere Artikel der Ausgabe 4/2019

International Urology and Nephrology 4/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.